The search strategy in three databases. حسب Zahra Tajik (20752452)

الموضوعات:

Summary of meta-analysis results to compare visfatin level before and after NSPT among cases with periodontitis and T2DM. حسب Zahra Tajik (20752452)

الموضوعات:

The comparison of GCF visfatin level before and three months after NSPT among cases with periodontitis. حسب Zahra Tajik (20752452)

الموضوعات:

A summary of the included study characteristics. حسب Zahra Tajik (20752452)

الموضوعات:

NIH score. حسب Zahra Tajik (20752452)

الموضوعات:

The comparison of saliva visfatin level before and three months after NSPT among cases with periodontitis. حسب Zahra Tajik (20752452)

الموضوعات:

The comparison of GCF visfatin level before and three months after NSPT among cases with periodontitis and T2DM. حسب Zahra Tajik (20752452)

الموضوعات:

List of excluded studies. حسب Zahra Tajik (20752452)

الموضوعات:

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Significant associations in GWAS. حسب Dai Nogimura (21445649)

"…<div><p>Decreased nitric oxide (NO) production from the vascular endothelium is a major factor for vascular aging. …"

Demonstration of decreased Aβ accumulation by DA-9601 treatment. حسب Mijung Lee (397790)

Prisma flow diagram of study selection. حسب Hattapark Dejakaisaya (22238613)

الموضوعات:

Sensitivity and subgroup analysis between higher TV watching time and cognitive scores. حسب Hattapark Dejakaisaya (22238613)

الموضوعات: